Expectations After Selecting The Consultation

Necessary Documentation

Shortly after signing up with AIM you will receive an email with documents you will need to read, answer, and execute. These documents include a general informed consent, a request for medical records/release, and a general health and allergies questionnaire. We require you to mail us the hard copy of these documents prior to scheduling a consultation. It is recommended that you complete and return these documents prior to scheduling a consultation.

Compiling Master Patient File And Initial Screening

Once AIM is in receipt of the necessary documentation we will compile a master medical file for the patient and forward to the Treating Physician who will conduct a pre-treatment screening. During this time you may receive a brief call or email from AIM in the event there is any questions from the physician. will be notified in your preferred method and asked that you schedule the consultation. This notification will include confirmation of your eligibility for AIM to safely begin developing an individualized treatment plan.

The Consultation and Treatment Plan

The patient will be directed to schedule an appointment for a video consultation with an attending physician. The primary purpose of the consultation is to narrow down a realistic treatmen and monitoring plan based on the patients personal objectives, overall health, medical history, and finances (which can have more of an effect on how close AIM will be able to monitor the patient's treatment and prognosis). The patient will be informed on the two treatments advocated by AIM, treatments believed industry wide to be tthe "gold standard" in treating aging as a disease..

AIM's consultation goal will be to assure each patient fully understands mechanism underlying the treatments and why AIM advocates for the same. Primary focuse on two treatments that have consistently produced significant benefits for patients in clinical trials, improving nearly every metric used to measure overall health and well being. These Targeted results are believed to enable a patient to maintain a healthy prognosis and ward off age related disease lwell beyond the treatment phase. AIM will utilize FDA approved drugs, as well as some natural supplements, which have impeccable track records and been shown in reputable scientific and medical journals to promote a robust cellular health and positively impacti an individuals's biological ageing process by slowing, stopping, and even in many cases, reversing the biological aging process.